ALISON COLLIER: Open Payments
NPI 1639553753 · SIMI VALLEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,177 in 164 payments from 19 companies in 2025. Trend: 2023 $2,864 · 2024 $2,775 · 2025 $3,177
Food & beverage: $3,177
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $624 |
| Janssen Biotech, Inc. | 23 | $435 |
| GENZYME CORPORATION | 13 | $416 |
| UCB, Inc. | 15 | $338 |
| LEO Pharma Inc. | 20 | $255 |
| Arcutis Biotherapeutics, Inc. | 8 | $174 |
| Novartis Pharmaceuticals Corporation | 7 | $173 |
| Galderma Laboratories, L.P. | 10 | $157 |
| Regeneron Healthcare Solutions, Inc. | 5 | $140 |
| Organon LLC | 9 | $116 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, Bimzelx, Zoryve, ADBRY, RINVOQ, NEMLUVIO.
Industry payments across CA — which companies pay providers there.
